LATEST ARTICLES WRITTEN BY Julien

Image by Julien

Julian

Editor-in-Chief specializing in CBD, Julien, born July 17, 1978, in the Paris region, is a leading writer and expert in the field of CBD products. Following his studies, Julien developed a passion for natural remedies, including CBD. In 2022, he joined the CBD.fr team as an expert and regular contributor. Thanks to his scientific expertise and clear writing style, Julien helps demystify the complexities of CBD, while highlighting its benefits and potential applications through his articles and conference presentations.
Buyer's Guide

CBD cigarettes: consumer reviews

CBD cigarettes are becoming increasingly popular on the French market. This rise in popularity is due to their relaxing effects and quality, attracting those looking for an alternative to traditional tobacco. The website CBD.fr, known for its high-quality products, offers a range

Buyer's Guide

Effects of CBD: Consumer Reviews

CBD, or cannabidiol, is gaining popularity for its many potential benefits. CBD products available on CBD.fr are often praised by consumers for their positive effects on health and well-being. But what do those who use them really think? This article

Cannabis and CBD News

CBD: A glimmer of hope for Alzheimer's patients

The alarming increase in the number of people affected by Alzheimer's disease has prompted researchers to explore innovative therapeutic approaches. According to a recent Colombian study, cannabidiol, better known as CBD, could play a crucial role in alleviating the symptoms of this neurodegenerative condition. Understanding the

Buyer's Guide

CBD, cannabidiol in 2025: consumer opinions

CBD, or cannabidiol, has gained popularity in recent years. By 2025, CBD products are ubiquitous and generating significant consumer interest. This article examines consumer opinions regarding CBD, its effects, regulations, and medical uses. The market boom

Cannabis and CBD News

Fiji is finalizing its legalization of medical cannabis

The Fijian government is working tirelessly to establish a legal medical cannabis industry. Minister of Commerce Manoa Kamikamica recently confirmed that the necessary legislation for this initiative is being finalized. This development represents a crucial turning point for Fiji

Cannabis and CBD News

The Australian medical cannabis industry: a booming market

Since its legalization in 2016, the Australian medical cannabis industry has experienced continuous growth. Recent figures and promising projections indicate that this market is poised for unprecedented expansion. With sales expected to quadruple compared to 2022, it is crucial to understand the factors driving this growth

Cannabis and CBD News

Brazil legalizes the cultivation, processing and sale of hemp

The landmark decision by Brazil's Superior Court of Justice (STJ) to approve the planting, cultivation, processing, and sale of hemp for medicinal purposes marks a turning point for the country. This legislative advancement opens new perspectives for the Brazilian medical industry and is generating considerable excitement

Buyer's Guide

CBD oil: consumer reviews on CBD.fr

CBD oil has become very popular in recent years, and many people praise its benefits. On the website CBD.fr, consumers share their experiences and highlight the effectiveness of CBD for various ailments. This article explores consumer reviews to give you an overview based on..

Cannabis and CBD News

California's legal cannabis generates $250 million in taxes in the third quarter

In California, the cannabis industry has experienced spectacular growth since the legalization of its recreational use. The latest statistics reveal that in the third quarter of 2024, cannabis taxes brought in over a quarter of a billion dollars for the state. But how did this pioneering region in legalization achieve this?

Cannabis and CBD News

CBD products authorized in the UK: a revolution expected by spring 2025

The year 2025 is shaping up to be a major turning point for the cannabidiol (CBD) industry in the UK. After years of waiting and debate, the first CBD-based products could finally receive official approval. This development, recently announced by the British regulatory body, is already generating considerable excitement among industry players